The North American Neuroendocrine Society (NANETS) Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

There have been significant developments in diagnostic and therapeutic options for patients with neuroendocrine tumors. Key phase III studies include the CLARINET trial which evaluated lanreotide in patients with non-functioning enteropancreatic NETs, the RADIANT 2 and RADIANT 4 studies, which evalu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pancreas
Autors principals: Strosberg, Jonathan R., Halfdanarson, Thorvardur R., Bellizzi, Andrew M., Chan, Jennifer A., Dillon, Joseph, Heaney, Anthony P., Kunz, Pamela L., O’Dorisio, Thomas M., Salem, Riad, Segelov, Eva, Howe, James, Pommier, Rodney, Brendtro, Kari, Bashir, Mohammad, Singh, Simron, Soulen, Michael C., Tang, Laura, Zacks, Jerome S., Yao, James, Bergsland, Emily
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642985/
https://ncbi.nlm.nih.gov/pubmed/28609356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000850
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars